GlassScriptPhysician profile
Cecilia Eunji Yu
NPI 1760859557
$315.38
in general payments reported to CMS, 2019-2025
11 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.67 · 2022: $35.16 · 2023: $38.05 · 2024: $41.49 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $50.74 | 2021-2024 | |
| Syndax Pharmaceuticals, INC. | $45.70 | 2025 | |
| Incyte Corporation | $36.96 | 2021-2025 | Niktimvo |
| Janssen Biotech, INC. | $33.30 | 2023-2024 | Tecvayli, Darzalex, Talvey |
| Legend Biotech USA INC. | $30.66 | 2025 | Carvykti |
| Autolus INC | $28.81 | 2025 | |
| Paratek Pharmaceuticals, INC. | $21.32 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.99 | 2023 | |
| Servier Pharmaceuticals LLC | $18.26 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.80 | 2021 | |
| Genentech USA, INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.